" /> CYP2C9 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen - CISMeF





Preferred Label : CYP2C9 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen;

LOINC status : ACTIVE;

LOINC display name : CYP2C9 gene product metabolic activity interpretation Molgen Ql (Bld/Tiss) [Interp];

LOINC long common name : CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method;

LOINC short name : CYP2C9 gene prod met act imp Bld/T-Imp;

LOINC description : The CYP2C9 gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting CYP2C9 gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html];

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.